HLN.L HALEON PLC ORD GBP0.01
Healthcare · Drug Manufacturers - Specialty & Generic
3.48
+0.03%
Sobre la empresa
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Perfil de dividendos
Calendario de pagos
Histórico de dividendos
Dividendo por acción por año
Deuda y apalancamiento
Últimas cifras del balance publicadas.
En manos de 1 inversor
Regístrate para obtener un resumen con IA del dividendo de esta acción — y para seguirla en tu cartera.
Información, no asesoramiento financiero.